 | • レポートコード：MRC308GR11395 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界のグリクラジド徐放性錠剤の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のグリクラジド徐放性錠剤市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– グリクラジド徐放性錠剤の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
グリクラジド徐放性錠剤市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・30mg、60mg、その他
用途別セグメント
・病院、診療所、その他
主要な市場プレーヤー
・Servier Laboratories、Torrent Pharmaceuticals、Aurobindo Pharma、Teva、Zydus Cadila Healthcare、Sanofi S.A.、Mylan Pharmaceuticals、Accord Healthcare、Lukang Jituan Saite Yaoye、Shijiazhuang SIYAO、Yiling Pharmaceutical
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、グリクラジド徐放性錠剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なグリクラジド徐放性錠剤メーカーの企業概要、2019年～2022年までのグリクラジド徐放性錠剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なグリクラジド徐放性錠剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別グリクラジド徐放性錠剤の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのグリクラジド徐放性錠剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのグリクラジド徐放性錠剤市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびグリクラジド徐放性錠剤の産業チェーンを掲載しています。
・第14、15章では、グリクラジド徐放性錠剤の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– グリクラジド徐放性錠剤の概要
– 種類別分析（2018年vs2022年vs2029年）：30mg、60mg、その他
– 用途別分析（2018年vs2022年vs2029年）：病院、診療所、その他
– 世界のグリクラジド徐放性錠剤市場規模・予測
– 世界のグリクラジド徐放性錠剤生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Servier Laboratories、Torrent Pharmaceuticals、Aurobindo Pharma、Teva、Zydus Cadila Healthcare、Sanofi S.A.、Mylan Pharmaceuticals、Accord Healthcare、Lukang Jituan Saite Yaoye、Shijiazhuang SIYAO、Yiling Pharmaceutical
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：30mg、60mg、その他
・用途別分析2018年-2029年：病院、診療所、その他
・グリクラジド徐放性錠剤の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・グリクラジド徐放性錠剤のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・グリクラジド徐放性錠剤のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・グリクラジド徐放性錠剤の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・グリクラジド徐放性錠剤の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Gliclazide Sustained-release Tablet
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Gliclazide Sustained-release Tablet Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 30mg
1.3.3 60mg
1.3.4 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Gliclazide Sustained-release Tablet Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Gliclazide Sustained-release Tablet Market Size & Forecast
1.5.1 Global Gliclazide Sustained-release Tablet Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Gliclazide Sustained-release Tablet Sales Quantity (2018-2029)
1.5.3 Global Gliclazide Sustained-release Tablet Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Servier Laboratories
2.1.1 Servier Laboratories Details
2.1.2 Servier Laboratories Major Business
2.1.3 Servier Laboratories Gliclazide Sustained-release Tablet Product and Services
2.1.4 Servier Laboratories Gliclazide Sustained-release Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Servier Laboratories Recent Developments/Updates
2.2 Torrent Pharmaceuticals
2.2.1 Torrent Pharmaceuticals Details
2.2.2 Torrent Pharmaceuticals Major Business
2.2.3 Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Product and Services
2.2.4 Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Torrent Pharmaceuticals Recent Developments/Updates
2.3 Aurobindo Pharma
2.3.1 Aurobindo Pharma Details
2.3.2 Aurobindo Pharma Major Business
2.3.3 Aurobindo Pharma Gliclazide Sustained-release Tablet Product and Services
2.3.4 Aurobindo Pharma Gliclazide Sustained-release Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Aurobindo Pharma Recent Developments/Updates
2.4 Teva
2.4.1 Teva Details
2.4.2 Teva Major Business
2.4.3 Teva Gliclazide Sustained-release Tablet Product and Services
2.4.4 Teva Gliclazide Sustained-release Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Teva Recent Developments/Updates
2.5 Zydus Cadila Healthcare
2.5.1 Zydus Cadila Healthcare Details
2.5.2 Zydus Cadila Healthcare Major Business
2.5.3 Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Product and Services
2.5.4 Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Zydus Cadila Healthcare Recent Developments/Updates
2.6 Sanofi S.A.
2.6.1 Sanofi S.A. Details
2.6.2 Sanofi S.A. Major Business
2.6.3 Sanofi S.A. Gliclazide Sustained-release Tablet Product and Services
2.6.4 Sanofi S.A. Gliclazide Sustained-release Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Sanofi S.A. Recent Developments/Updates
2.7 Mylan Pharmaceuticals
2.7.1 Mylan Pharmaceuticals Details
2.7.2 Mylan Pharmaceuticals Major Business
2.7.3 Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Product and Services
2.7.4 Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Mylan Pharmaceuticals Recent Developments/Updates
2.8 Accord Healthcare
2.8.1 Accord Healthcare Details
2.8.2 Accord Healthcare Major Business
2.8.3 Accord Healthcare Gliclazide Sustained-release Tablet Product and Services
2.8.4 Accord Healthcare Gliclazide Sustained-release Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Accord Healthcare Recent Developments/Updates
2.9 Lukang Jituan Saite Yaoye
2.9.1 Lukang Jituan Saite Yaoye Details
2.9.2 Lukang Jituan Saite Yaoye Major Business
2.9.3 Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Product and Services
2.9.4 Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Lukang Jituan Saite Yaoye Recent Developments/Updates
2.10 Shijiazhuang SIYAO
2.10.1 Shijiazhuang SIYAO Details
2.10.2 Shijiazhuang SIYAO Major Business
2.10.3 Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Product and Services
2.10.4 Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Shijiazhuang SIYAO Recent Developments/Updates
2.11 Yiling Pharmaceutical
2.11.1 Yiling Pharmaceutical Details
2.11.2 Yiling Pharmaceutical Major Business
2.11.3 Yiling Pharmaceutical Gliclazide Sustained-release Tablet Product and Services
2.11.4 Yiling Pharmaceutical Gliclazide Sustained-release Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Yiling Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Gliclazide Sustained-release Tablet by Manufacturer
3.1 Global Gliclazide Sustained-release Tablet Sales Quantity by Manufacturer (2018-2023)
3.2 Global Gliclazide Sustained-release Tablet Revenue by Manufacturer (2018-2023)
3.3 Global Gliclazide Sustained-release Tablet Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Gliclazide Sustained-release Tablet by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Gliclazide Sustained-release Tablet Manufacturer Market Share in 2022
3.4.2 Top 6 Gliclazide Sustained-release Tablet Manufacturer Market Share in 2022
3.5 Gliclazide Sustained-release Tablet Market: Overall Company Footprint Analysis
3.5.1 Gliclazide Sustained-release Tablet Market: Region Footprint
3.5.2 Gliclazide Sustained-release Tablet Market: Company Product Type Footprint
3.5.3 Gliclazide Sustained-release Tablet Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Gliclazide Sustained-release Tablet Market Size by Region
4.1.1 Global Gliclazide Sustained-release Tablet Sales Quantity by Region (2018-2029)
4.1.2 Global Gliclazide Sustained-release Tablet Consumption Value by Region (2018-2029)
4.1.3 Global Gliclazide Sustained-release Tablet Average Price by Region (2018-2029)
4.2 North America Gliclazide Sustained-release Tablet Consumption Value (2018-2029)
4.3 Europe Gliclazide Sustained-release Tablet Consumption Value (2018-2029)
4.4 Asia-Pacific Gliclazide Sustained-release Tablet Consumption Value (2018-2029)
4.5 South America Gliclazide Sustained-release Tablet Consumption Value (2018-2029)
4.6 Middle East and Africa Gliclazide Sustained-release Tablet Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Gliclazide Sustained-release Tablet Sales Quantity by Type (2018-2029)
5.2 Global Gliclazide Sustained-release Tablet Consumption Value by Type (2018-2029)
5.3 Global Gliclazide Sustained-release Tablet Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Gliclazide Sustained-release Tablet Sales Quantity by Application (2018-2029)
6.2 Global Gliclazide Sustained-release Tablet Consumption Value by Application (2018-2029)
6.3 Global Gliclazide Sustained-release Tablet Average Price by Application (2018-2029)
7 North America
7.1 North America Gliclazide Sustained-release Tablet Sales Quantity by Type (2018-2029)
7.2 North America Gliclazide Sustained-release Tablet Sales Quantity by Application (2018-2029)
7.3 North America Gliclazide Sustained-release Tablet Market Size by Country
7.3.1 North America Gliclazide Sustained-release Tablet Sales Quantity by Country (2018-2029)
7.3.2 North America Gliclazide Sustained-release Tablet Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Gliclazide Sustained-release Tablet Sales Quantity by Type (2018-2029)
8.2 Europe Gliclazide Sustained-release Tablet Sales Quantity by Application (2018-2029)
8.3 Europe Gliclazide Sustained-release Tablet Market Size by Country
8.3.1 Europe Gliclazide Sustained-release Tablet Sales Quantity by Country (2018-2029)
8.3.2 Europe Gliclazide Sustained-release Tablet Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Gliclazide Sustained-release Tablet Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Gliclazide Sustained-release Tablet Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Gliclazide Sustained-release Tablet Market Size by Region
9.3.1 Asia-Pacific Gliclazide Sustained-release Tablet Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Gliclazide Sustained-release Tablet Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Gliclazide Sustained-release Tablet Sales Quantity by Type (2018-2029)
10.2 South America Gliclazide Sustained-release Tablet Sales Quantity by Application (2018-2029)
10.3 South America Gliclazide Sustained-release Tablet Market Size by Country
10.3.1 South America Gliclazide Sustained-release Tablet Sales Quantity by Country (2018-2029)
10.3.2 South America Gliclazide Sustained-release Tablet Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Gliclazide Sustained-release Tablet Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Gliclazide Sustained-release Tablet Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Gliclazide Sustained-release Tablet Market Size by Country
11.3.1 Middle East & Africa Gliclazide Sustained-release Tablet Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Gliclazide Sustained-release Tablet Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Gliclazide Sustained-release Tablet Market Drivers
12.2 Gliclazide Sustained-release Tablet Market Restraints
12.3 Gliclazide Sustained-release Tablet Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Gliclazide Sustained-release Tablet and Key Manufacturers
13.2 Manufacturing Costs Percentage of Gliclazide Sustained-release Tablet
13.3 Gliclazide Sustained-release Tablet Production Process
13.4 Gliclazide Sustained-release Tablet Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Gliclazide Sustained-release Tablet Typical Distributors
14.3 Gliclazide Sustained-release Tablet Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Gliclazide Sustained-release Tablet Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Gliclazide Sustained-release Tablet Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Servier Laboratories Basic Information, Manufacturing Base and Competitors
Table 4. Servier Laboratories Major Business
Table 5. Servier Laboratories Gliclazide Sustained-release Tablet Product and Services
Table 6. Servier Laboratories Gliclazide Sustained-release Tablet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Servier Laboratories Recent Developments/Updates
Table 8. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 9. Torrent Pharmaceuticals Major Business
Table 10. Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Product and Services
Table 11. Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Torrent Pharmaceuticals Recent Developments/Updates
Table 13. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Aurobindo Pharma Major Business
Table 15. Aurobindo Pharma Gliclazide Sustained-release Tablet Product and Services
Table 16. Aurobindo Pharma Gliclazide Sustained-release Tablet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Aurobindo Pharma Recent Developments/Updates
Table 18. Teva Basic Information, Manufacturing Base and Competitors
Table 19. Teva Major Business
Table 20. Teva Gliclazide Sustained-release Tablet Product and Services
Table 21. Teva Gliclazide Sustained-release Tablet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Teva Recent Developments/Updates
Table 23. Zydus Cadila Healthcare Basic Information, Manufacturing Base and Competitors
Table 24. Zydus Cadila Healthcare Major Business
Table 25. Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Product and Services
Table 26. Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Zydus Cadila Healthcare Recent Developments/Updates
Table 28. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 29. Sanofi S.A. Major Business
Table 30. Sanofi S.A. Gliclazide Sustained-release Tablet Product and Services
Table 31. Sanofi S.A. Gliclazide Sustained-release Tablet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Sanofi S.A. Recent Developments/Updates
Table 33. Mylan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 34. Mylan Pharmaceuticals Major Business
Table 35. Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Product and Services
Table 36. Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Mylan Pharmaceuticals Recent Developments/Updates
Table 38. Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table 39. Accord Healthcare Major Business
Table 40. Accord Healthcare Gliclazide Sustained-release Tablet Product and Services
Table 41. Accord Healthcare Gliclazide Sustained-release Tablet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Accord Healthcare Recent Developments/Updates
Table 43. Lukang Jituan Saite Yaoye Basic Information, Manufacturing Base and Competitors
Table 44. Lukang Jituan Saite Yaoye Major Business
Table 45. Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Product and Services
Table 46. Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Lukang Jituan Saite Yaoye Recent Developments/Updates
Table 48. Shijiazhuang SIYAO Basic Information, Manufacturing Base and Competitors
Table 49. Shijiazhuang SIYAO Major Business
Table 50. Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Product and Services
Table 51. Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Shijiazhuang SIYAO Recent Developments/Updates
Table 53. Yiling Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. Yiling Pharmaceutical Major Business
Table 55. Yiling Pharmaceutical Gliclazide Sustained-release Tablet Product and Services
Table 56. Yiling Pharmaceutical Gliclazide Sustained-release Tablet Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Yiling Pharmaceutical Recent Developments/Updates
Table 58. Global Gliclazide Sustained-release Tablet Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Gliclazide Sustained-release Tablet Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Gliclazide Sustained-release Tablet Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Gliclazide Sustained-release Tablet, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Gliclazide Sustained-release Tablet Production Site of Key Manufacturer
Table 63. Gliclazide Sustained-release Tablet Market: Company Product Type Footprint
Table 64. Gliclazide Sustained-release Tablet Market: Company Product Application Footprint
Table 65. Gliclazide Sustained-release Tablet New Market Entrants and Barriers to Market Entry
Table 66. Gliclazide Sustained-release Tablet Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Gliclazide Sustained-release Tablet Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Gliclazide Sustained-release Tablet Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Gliclazide Sustained-release Tablet Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Gliclazide Sustained-release Tablet Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Gliclazide Sustained-release Tablet Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Gliclazide Sustained-release Tablet Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Gliclazide Sustained-release Tablet Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Gliclazide Sustained-release Tablet Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Gliclazide Sustained-release Tablet Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Gliclazide Sustained-release Tablet Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Gliclazide Sustained-release Tablet Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Gliclazide Sustained-release Tablet Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Gliclazide Sustained-release Tablet Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Gliclazide Sustained-release Tablet Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Gliclazide Sustained-release Tablet Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Gliclazide Sustained-release Tablet Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Gliclazide Sustained-release Tablet Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Gliclazide Sustained-release Tablet Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Gliclazide Sustained-release Tablet Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Gliclazide Sustained-release Tablet Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Gliclazide Sustained-release Tablet Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Gliclazide Sustained-release Tablet Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Gliclazide Sustained-release Tablet Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Gliclazide Sustained-release Tablet Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Gliclazide Sustained-release Tablet Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Gliclazide Sustained-release Tablet Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Gliclazide Sustained-release Tablet Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Gliclazide Sustained-release Tablet Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Gliclazide Sustained-release Tablet Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Gliclazide Sustained-release Tablet Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Gliclazide Sustained-release Tablet Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Gliclazide Sustained-release Tablet Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Gliclazide Sustained-release Tablet Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Gliclazide Sustained-release Tablet Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Gliclazide Sustained-release Tablet Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Gliclazide Sustained-release Tablet Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Gliclazide Sustained-release Tablet Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Gliclazide Sustained-release Tablet Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Gliclazide Sustained-release Tablet Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Gliclazide Sustained-release Tablet Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Gliclazide Sustained-release Tablet Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Gliclazide Sustained-release Tablet Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Gliclazide Sustained-release Tablet Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Gliclazide Sustained-release Tablet Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Gliclazide Sustained-release Tablet Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Gliclazide Sustained-release Tablet Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Gliclazide Sustained-release Tablet Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Gliclazide Sustained-release Tablet Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Gliclazide Sustained-release Tablet Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Gliclazide Sustained-release Tablet Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Gliclazide Sustained-release Tablet Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Gliclazide Sustained-release Tablet Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Gliclazide Sustained-release Tablet Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Gliclazide Sustained-release Tablet Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Gliclazide Sustained-release Tablet Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Gliclazide Sustained-release Tablet Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Gliclazide Sustained-release Tablet Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Gliclazide Sustained-release Tablet Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Gliclazide Sustained-release Tablet Raw Material
Table 126. Key Manufacturers of Gliclazide Sustained-release Tablet Raw Materials
Table 127. Gliclazide Sustained-release Tablet Typical Distributors
Table 128. Gliclazide Sustained-release Tablet Typical Customers
List of Figures
Figure 1. Gliclazide Sustained-release Tablet Picture
Figure 2. Global Gliclazide Sustained-release Tablet Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Gliclazide Sustained-release Tablet Consumption Value Market Share by Type in 2022
Figure 4. 30mg Examples
Figure 5. 60mg Examples
Figure 6. Other Examples
Figure 7. Global Gliclazide Sustained-release Tablet Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Gliclazide Sustained-release Tablet Consumption Value Market Share by Application in 2022
Figure 9. Hospital Examples
Figure 10. Clinic Examples
Figure 11. Other Examples
Figure 12. Global Gliclazide Sustained-release Tablet Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Gliclazide Sustained-release Tablet Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Gliclazide Sustained-release Tablet Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Gliclazide Sustained-release Tablet Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Gliclazide Sustained-release Tablet Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Gliclazide Sustained-release Tablet Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Gliclazide Sustained-release Tablet by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Gliclazide Sustained-release Tablet Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Gliclazide Sustained-release Tablet Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Gliclazide Sustained-release Tablet Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Gliclazide Sustained-release Tablet Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Gliclazide Sustained-release Tablet Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Gliclazide Sustained-release Tablet Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Gliclazide Sustained-release Tablet Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Gliclazide Sustained-release Tablet Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Gliclazide Sustained-release Tablet Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Gliclazide Sustained-release Tablet Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Gliclazide Sustained-release Tablet Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Gliclazide Sustained-release Tablet Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Gliclazide Sustained-release Tablet Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Gliclazide Sustained-release Tablet Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Gliclazide Sustained-release Tablet Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Gliclazide Sustained-release Tablet Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Gliclazide Sustained-release Tablet Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Gliclazide Sustained-release Tablet Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Gliclazide Sustained-release Tablet Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Gliclazide Sustained-release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Gliclazide Sustained-release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Gliclazide Sustained-release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Gliclazide Sustained-release Tablet Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Gliclazide Sustained-release Tablet Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Gliclazide Sustained-release Tablet Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Gliclazide Sustained-release Tablet Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Gliclazide Sustained-release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Gliclazide Sustained-release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Gliclazide Sustained-release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Gliclazide Sustained-release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Gliclazide Sustained-release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Gliclazide Sustained-release Tablet Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Gliclazide Sustained-release Tablet Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Gliclazide Sustained-release Tablet Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Gliclazide Sustained-release Tablet Consumption Value Market Share by Region (2018-2029)
Figure 54. China Gliclazide Sustained-release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Gliclazide Sustained-release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Gliclazide Sustained-release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Gliclazide Sustained-release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Gliclazide Sustained-release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Gliclazide Sustained-release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Gliclazide Sustained-release Tablet Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Gliclazide Sustained-release Tablet Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Gliclazide Sustained-release Tablet Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Gliclazide Sustained-release Tablet Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Gliclazide Sustained-release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Gliclazide Sustained-release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Gliclazide Sustained-release Tablet Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Gliclazide Sustained-release Tablet Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Gliclazide Sustained-release Tablet Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Gliclazide Sustained-release Tablet Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Gliclazide Sustained-release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Gliclazide Sustained-release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Gliclazide Sustained-release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Gliclazide Sustained-release Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Gliclazide Sustained-release Tablet Market Drivers
Figure 75. Gliclazide Sustained-release Tablet Market Restraints
Figure 76. Gliclazide Sustained-release Tablet Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Gliclazide Sustained-release Tablet in 2022
Figure 79. Manufacturing Process Analysis of Gliclazide Sustained-release Tablet
Figure 80. Gliclazide Sustained-release Tablet Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source